date,title,source
Nov-06-18,Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Nov-09-18,"Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-09-18,Adamis: 3Q Earnings Snapshot,Associated Press
Nov-09-18,Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business Update,GlobeNewswire
Nov-28-18,Teva (TEVA) Launches First Generic Version of Mylan's EpiPen,Zacks
Dec-06-18,Novartis to launch Adamis' EpiPen rival in U.S. next year,Reuters
Dec-06-18,Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI,GlobeNewswire
Dec-17-18,Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options,Zacks
Dec-21-18,Adamis Pharmaceuticals (ADMP) Jumps: Stock Rises 5.3%,Zacks
Dec-28-18,Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet,GlobeNewswire
Dec-31-18,Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe,GlobeNewswire
Dec-31-18,4 Pharma Stocks Gaining Speed on Monday (12/31/18),ACCESSWIRE
Jan-02-19,"Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James",Benzinga
Jan-03-19,"Detailed Research: Economic Perspectives on Biohaven Pharmaceutical Holding, Air Transport Services Group, Pattern Energy Group, First Solar, Limelight Networks, and Adamis Pharmaceuticals  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Jan-16-19,Adamis stock surges on release of EpiPen alternative,MarketWatch
Jan-16-19,Adamis Commercial Partner Launches SYMJEPI (epinephrine) in the US,GlobeNewswire
Jan-17-19,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",Benzinga
Jan-17-19,Today's Research Reports on Trending Tickers: Adamis Pharmaceuticals and Biocept,ACCESSWIRE
Jan-23-19,Is Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Excessively Paying Its CEO?,Simply Wall St.
Feb-20-19,Adamis Pharmaceuticals Publishes the Rationale for a Higher Dose Naloxone Product to Counter the Current Opioid Epidemic,GlobeNewswire
Feb-26-19,Adamis Provides Regulatory Update on Sublingual Tadalafil,GlobeNewswire
Feb-27-19,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",Benzinga
Mar-13-19,"Before You Buy Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Consider Its Volatility",Simply Wall St.
Mar-14-19,Adamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection Product Candidate,Business Wire
Mar-14-19,Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release,Zacks
